Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s HE Karim-Kos, E de Vries, I Soerjomataram, V Lemmens, S Siesling, ... European journal of cancer 44 (10), 1345-1389, 2008 | 971 | 2008 |
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory M Arnold, HE Karim-Kos, JW Coebergh, G Byrnes, A Antilla, J Ferlay, ... European journal of cancer 51 (9), 1164-1187, 2015 | 702 | 2015 |
Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma MJA Engelen, HE Kos, PHB Willemse, JG Aalders, EGE de Vries, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 385 | 2006 |
The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival F Asadzadeh Vostakolaei, HE Karim-Kos, MLG Janssen-Heijnen, ... The European Journal of Public Health 21 (5), 573-577, 2011 | 207 | 2011 |
Centralization of esophageal cancer surgery: does it improve clinical outcome? MWJM Wouters, HE Karim-Kos, S le Cessie, BPL Wijnhoven, ... Annals of surgical oncology 16, 1789-1798, 2009 | 179 | 2009 |
Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989 LM Hollestein, SAW Van den Akker, T Nijsten, HE Karim-Kos, ... Annals of oncology 23 (2), 524-530, 2012 | 175 | 2012 |
HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma A Diepstra, GW van Imhoff, HE Karim-Kos, A van den Berg, ... Journal of clinical oncology 25 (21), 3101-3108, 2007 | 164 | 2007 |
Socioeconomic inequalities in neglected tropical diseases: a systematic review TAJ Houweling, HE Karim-Kos, MC Kulik, WA Stolk, JA Haagsma, ... PLoS neglected tropical diseases 10 (5), e0004546, 2016 | 158 | 2016 |
Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006 LN Van Steenbergen, MAG Elferink, P Krijnen, V Lemmens, S Siesling, ... Annals of oncology 21 (11), 2206-2212, 2010 | 150 | 2010 |
Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin’s lymphoma predicts adverse outcome in older adult patients A Diepstra, GW van Imhoff, M Schaapveld, H Karim-Kos, A van den Berg, ... J Clin Oncol 27 (23), 3815-21, 2009 | 120 | 2009 |
Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006 MAG Elferink, LN Van Steenbergen, P Krijnen, V Lemmens, HJ Rutten, ... European journal of cancer 46 (8), 1421-1429, 2010 | 94 | 2010 |
Breast cancer in South Asia: a Bangladeshi perspective MS Hossain, S Ferdous, HE Karim-Kos Cancer epidemiology 38 (5), 465-470, 2014 | 92 | 2014 |
Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989–2006 RGHM Cremers, HE Karim-Kos, S Houterman, RHA Verhoeven, ... European journal of cancer 46 (11), 2077-2087, 2010 | 82 | 2010 |
Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark R Jacobsen, H Møller, SØ Thoresen, E Pukkala, SK Kjaer, C Johansen International journal of andrology 29 (1), 199-204, 2006 | 82 | 2006 |
Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years MA Van der Drift, HE Karim-Kos, S Siesling, HJM Groen, MWJM Wouters, ... Journal of thoracic oncology 7 (2), 291-298, 2012 | 81 | 2012 |
Progress against laryngeal cancer in The Netherlands between 1989 and 2010 BAC van Dijk, HE Karim‐Kos, JW Coebergh, HAM Marres, E de Vries International journal of cancer 134 (3), 674-681, 2014 | 76 | 2014 |
Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached? IMCM de Kok, MA van der Aa, M van Ballegooijen, S Siesling, ... International journal of cancer 128 (9), 2174-2181, 2011 | 75 | 2011 |
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study L Botta, G Gatta, R Capocaccia, C Stiller, A Cañete, L Dal Maso, K Innos, ... The Lancet Oncology 23 (12), 1525-1536, 2022 | 66 | 2022 |
Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989 O Husson, HR Haak, LN van Steenbergen, WA Nieuwlaat, BAC van Dijk, ... Endocrine-related cancer 20 (2), 263-271, 2013 | 65 | 2013 |
Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival CDM Witjes, HE Karim‐Kos, O Visser, E de Vries, JNM IJzermans, ... Hpb 14 (11), 777-781, 2012 | 64 | 2012 |